Sargent Bickham Lagudis’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.44M | Sell |
|
|||||
|
2022
Q3 | $2.48M | Sell |
|
|||||
|
2022
Q2 | $2.88M | Buy |
|
|||||
|
2022
Q1 | $2.54M | Sell |
|
|||||
|
2021
Q4 | $2.76M | Sell |
|
|||||
|
2021
Q3 | $4.1M | Buy |
|
|||||
|
2021
Q2 | $4.57M | Buy |
|
|||||
|
2021
Q1 | $4.18M | Buy |
|
|||||
|
2020
Q4 | $3.84M | Buy |
|
|||||
|
2020
Q3 | $3.65M | Buy |
|
|||||
|
2020
Q2 | $3.25M | Buy |
|
|||||
|
2020
Q1 | $1.04M | Sell |
|
|||||
|
2019
Q4 | $1.25M | Buy |
|
|||||
|
2019
Q3 | $924K | Buy |
|
|||||
|
2019
Q2 | $821K | Buy |
|
|||||
|
2019
Q1 | $863K | Sell |
|
|||||
|
2018
Q4 | $950K | Buy |
|
|||||
|
2018
Q3 | $1.12M | Sell |
|
|||||
|
2018
Q2 | $1.03M | Sell |
|
|||||
|
2018
Q1 | $1.23M | Sell |
|
|||||
|
2017
Q4 | $1.21M | Buy |
|
|||||
|
2017
Q3 | $1.22M | Buy |
|
|||||
|
2017
Q2 | $1.05M | Sell |
|
|||||
|
2017
Q1 | $1.03M | Sell |
|
|||||
|
2016
Q4 | $1.19M | Sell |
|
|||||
|
2016
Q3 | $1.13K | Sell |
|
|||||
|
2016
Q2 | $1.58M | Sell |
|
|||||
|
2016
Q1 | $1.4M | Buy |
|